FIELD: chemistry.
SUBSTANCE: invention relates to genetic engineering, namely, to obtaining inhibitors of TGF-β1 and can be used in medicine. Obtained peptides are capable of binding with transforming growth factor TGF-β1 and are potential inhibitors of biological activity of TGF-β1, binding with this cytokine directly. Peptides are obtained by recombinant method using transformed host-cell, by cultivating host-cell in conditions which ensure production of the said peptide, and its separation. The invention allows for efficiently treatment of diseases or pathological disorders connected with hyperexpression or disregulated expression of TGF-β1.
EFFECT: possibility to efficiently treat diseases or pathological disorders connected with hyperexpression or disregulated expression of TGF-β1.
12 cl, 6 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF DNA SEQUENCE WHICH CODES PEPTIDE ABLE TO BIND WITH TRANSFORMING GROWTH FACTOR β1 (VERSIONS) | 2008 |
|
RU2455358C2 |
| PEPTIDES HAVING CAPACITY TO BIND WITH SCURFIN AND USE THEREOF | 2008 |
|
RU2502741C2 |
| ANTI-GARP-TGF-β-ANTIBODIES | 2018 |
|
RU2767784C2 |
| APPLICATION OF INHIBITING TGF-beta1 PEPTIDES FOR PREPARATION OF AGENT MODULATING IMMUNE RESPONSE | 2005 |
|
RU2420307C2 |
| INHIBITORS OF SIGNAL TRANSMISSION OF TRANSFORMING GROWTH FACTORS (TGF-R) FOR TREATMENT OF CNS DISORDERS | 2005 |
|
RU2385933C2 |
| DNA ENCODING NEW RGI PEPTIDE | 2000 |
|
RU2283130C2 |
| PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 | 2008 |
|
RU2488592C2 |
| SPARC-BINDING PEPTIDES AND USING THEM | 2009 |
|
RU2491085C2 |
| INTEGRIN ανβ8 NEUTRALISING ANTIBODIES | 2011 |
|
RU2565539C2 |
| ALPHA-V BETA-8-BINDING ANTIBODIES | 2012 |
|
RU2614252C2 |
